Dysregulation of HSG triggers vascular proliferative disorders
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Vascular proliferative disorders, such as atherosclerosis and restenosis, are the most common causes of severe cardiovascular diseases, but a common molecular mechanism remains elusive. Here, we identify and characterize a novel hyperplasia suppressor gene, named HSG (later re-named rat mitofusin-2). HSG expression was markedly reduced in hyper-proliferative vascular smooth muscle cells (VSMCs) from spontaneously hypertensive rat arteries, balloon-injured Wistar Kyoto rat arteries, or ApoE-knockout mouse atherosclerotic arteries. Overexpression of HSG overtly suppressed serum-evoked VSMC proliferation in culture, and blocked balloon injury induced neointimal VSMC proliferation and restenosis in rat carotid arteries. The HSG anti-proliferative effect was mediated by inhibition of ERK/MAPK signalling and subsequent cell-cycle arrest. Deletion of the p21(ras) signature motif, but not the mitochondrial targeting domain, abolished HSG-induced growth arrest, indicating that rHSG-induced anti-proliferation was independent of mitochondrial fusion. Thus, rHSG functions as a cell proliferation suppressor, whereas dysregulation of rHSG results in proliferative disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Besides its role in mitochondrial fusion, Mfn2 has been described to be involved in the regulation of cell proliferation, oxidative metabolism, autophagy, mitophagy, mitochondrial antiviral signaling, and unfolded protein response (Bach et al, 2003; Chen et al, 2004; Yasukawa et al, 2009; Hailey et al, 2010; Ngoh et al, 2012; Zhao et al, 2012; Chen & Dorn, 2013; Munoz et al, 2013).”
From Mfn2 deficiency links age‐related sarcopenia and impaired autophagy to activation of an adaptive mitophagy pathway (2016) · cites this paper as Chen et al, 2004
In the citing paper
“Recently, it has been reported that Mfn2 binds Ras and its overexpression inhibits extracellular signalrelated kinase/mitogen-activated protein kinase signaling and subsequently arrests cell cycle (30).”
From Expression of Mfn2, the Charcot-Marie-Tooth Neuropathy Type 2A Gene, in Human Skeletal Muscle (2005) · cites this paper as [30]
Citations
Cites
Moses, J. W., Leon, M. B., Popma, J. J., Fitzgerald, P. J., Holmes, D. R., O'Shaughnessy, C., Caputo, R. P., Kereiakes, D. J., Williams, D. O., Teirstein, P. S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035071 · Cited by 4,224 · cited 1×
“Recent studies indicate that coated stents with anti-proliferative agents, including rapamyci”
BackgroundMarshall, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90401-8 · Cited by 3,906 · cited 1×
“The Ras proto-oncogene is a central component of mitogenic signalling pathways, and is essential for cells to exit a quiescent state (G0) and to pass through the G1–S transition of the cell cycl”
BackgroundChen, H., Detmer, S. A., Ewald, A. J., Griffin, E. E., Fraser, S. E., & Chan, D. C. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200211046 · Cited by 2,601 · cited 1×
“Several studies have demonstrated that human Mfn-2 and its homologues localize to the mitochondrial outer membrane and have an essential role in mitochondrial fusion, thus regulating mitochondrial morphology and function in mammalian cells, yeast and flie”
BackgroundDevelopment of a Strain of Spontaneously Hypertensive Rats
OKAMOTO, K., & AOKI, K. (1963) · Japanese Circulation Journal · doi:10.1253/jcj.27.282 · Cited by 2,545
Polyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., & Massagué, J. (1994) · Cell · doi:10.1016/0092-8674(94)90572-x · Cited by 2,118
Nakayama, K., Ishida, N., Shirane, M., Inomata, A., Inoue, T., Shishido, N., Horii, I., Loh, D. Y., & Nakayama, K.-I. (1996) · Cell · doi:10.1016/s0092-8674(00)81237-4 · Cited by 1,547
Fero, M. L., Rivkin, M., Tasch, M., Porter, P., Carow, C. E., Firpo, E., Polyak, K., Tsai, L.-H., Broudy, V., Perlmutter, R. M., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81239-8 · Cited by 1,457
Tunstall-Pedoe, H., Kuulasmaa, K., Mähönen, M., Tolonen, H., & Ruokokoski, E. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04021-0 · Cited by 1,444
Clowes, A. W., Reidy, M. A., & Clowes, M. M. (1983) · PubMed · Cited by 1,437
Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome
Srivastava, S., Zou, Z., Pirollo, K., Blattner, W., & Chang, E. H. (1990) · Nature · doi:10.1038/348747a0 · Cited by 1,211 · cited 1×
“In fact, the anti-proliferative effect of human HSG is more potent than that induced by overexpression of p53, a well established tumour suppresso”
Background
Cited by
Items 101–200 of 368
AIM2 promotes the development of non-small cell lung cancer by modulating mitochondrial dynamics
Qi, M., Dai, D., Liu, J., Li, Z., Liang, P., Wang, Y., Lu, C., Zhan, Y., An, Z., Song, Y., et al. (2020) · Oncogene · doi:10.1038/s41388-020-1176-9 · Cited by 100
Opening the doors to cytochrome c: Changes in mitochondrial shape and apoptosis
Scorrano, L. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.04.016 · Cited by 95
Feng, S., Gao, L., Zhang, D., Tian, X., Kong, L., Shi, H., Wu, L., Huang, Z. J., Du, B., Liang, C., et al. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.36995 · Cited by 96
Ushio‐Fukai, M., Ash, D., Nagarkoti, S., de Chantemèle, E. J. B., Fulton, D. J., & Fukai, T. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8161 · Cited by 102
“As an example, reduced expression of Mfn2 led to hyperproliferation of VSMCs and accelerated cardiac hypertrophy and cardiomyopathy in mouse and rat models (46).”
Mechanistic perspective of mitochondrial fusion: Tubulation vs. fragmentation
Escobar‐Henriques, M., & den Brave, F. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.07.016 · Cited by 110
Wang, W., Lu, J., Zhu, F., Wei, J., Jia, C., Zhang, Y., Zhou, L., Xie, H., & Zheng, S. (2010) · Medical Oncology · doi:10.1007/s12032-010-9779-6 · Cited by 93
“Mfn2, a novel hyperplasia suppressor gene, was first identified based on its marked downregulation in VSMCs of spontaneously hypertensive rats [1].”
Aravamudan, B., Thompson, M. A., Pabelick, C. M., & Prakash, Y. S. (2013) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2013.834252 · Cited by 91
Vascular aging: Molecular mechanisms and potential treatments for vascular rejuvenation
Mistriotis, P., & Andreadis, S. T. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.05.006 · Cited by 92
Li, Y. E., Sowers, J. R., Hetz, C. A., & Ren, J. T. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04942-2 · Cited by 102
Mitofusin 2 as a Driver That Controls Energy Metabolism and Insulin Signaling
Zorzano, A., Hernández-Alvarez, M. I., Sebastián, D., & Muñoz, J. P. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.6208 · Cited by 82
“…have been associated with neuropathies (Charcot-Marie-Tooth type 2A and autosomal dominant hereditary optic neuropathy or ADOA) (4, 24, 119), neurodegenerative disorders such as Parkinson’s disease (63), atherosclerosis (16), and metabolic diseases such as obesity and type 2 diabetes (8, 86, 87).”
Tying trafficking to fusion and fission at the mighty mitochondria
Farmer, T., Naslavsky, N., & Caplan, S. (2018) · Traffic · doi:10.1111/tra.12573 · Cited by 81
“Mfn1 and Mfn2 are OMM transmembrane GTPases that contain several conserved domains, such as an amino-terminal GTP-binding domain, 2 coiled-coil domains and a carboxyl-terminal with a bipartite transmembrane domain.25 The difference between the Mfn1 and Mfn2 is that Mfn2 has an N-terminal Ras-binding domain that is lac…”
BackgroundTwo Close, Too Close: Sarcoplasmic Reticulum–Mitochondrial Crosstalk and Cardiomyocyte Fate
Dorn, G. W., & Scorrano, L. (2010) · Circulation Research · doi:10.1161/circresaha.110.225714 · Cited by 86
Small molecule agonist of mitochondrial fusion repairs mitochondrial dysfunction
Guo, Y., Zhang, H., Chen, Y., Shen, B., Zhang, Y., Guo, X., Sun, S., Fan, Y., Yan, J., Liu, R., et al. (2023) · Nature Chemical Biology · doi:10.1038/s41589-022-01224-y · Cited by 90
Self-citationNF1 Regulates a Ras-Dependent Vascular Smooth Muscle Proliferative Injury Response
Xu, J., Ismat, F. A., Wang, T., Yang, J., & Epstein, J. A. (2007) · Circulation · doi:10.1161/circulationaha.107.707752 · Cited by 80
Implications of mitochondrial dynamics on neurodegeneration and on hypothalamic dysfunction
Zorzano, A., & Claret, M. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00101 · Cited by 79
“Mfn2 has been proposed to regulate cell proliferation and mitochondrial metabolism (Bach et al., 2003; Chen et al., 2004a, 2014; Pich et al., 2005).”
BackgroundNeurofibromin is a novel regulator of RAS-induced signals in primary vascular smooth muscle cells
Li, F., Munchhof, A. M., White, H. A., Mead, L. E., Krier, T. R., Fenoglio, A., Shi, C., Wu, X., Cai, S., Yang, F., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl114 · Cited by 84
Alexa‐Stratulat, T., Pešić, M., Gašparović, A. Č., Trougakos, I. P., & Riganti, C. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.100643 · Cited by 80
Zhou, X., Zhang, L., Zheng, B., Yan, Y., Zhang, Y., Xie, H., Zhou, L., Zheng, S., & Wang, W. (2016) · Cancer Science · doi:10.1111/cas.12904 · Cited by 77
miR-106a promotes cardiac hypertrophy by targeting mitofusin 2
Guan, X., Wang, L., Liu, Z., Guo, X., Jiang, Y., Lu, Y., Peng, Y., Liu, T., Yang, B., Shan, H., et al. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.08.016 · Cited by 73
“Mfn2 is known as a cell proliferation suppressor gene, probably by inhibiting the MAPK/ERK pathway[15, 22].”
BackgroundSelf-citationDong, L., Wen, J., Liu, G., McNutt, M. A., Miao, S., Gao, R., Zheng, B., Zhang, H., & Han, M. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.200501 · Cited by 72
Mitofusin 2 in Mature Adipocytes Controls Adiposity and Body Weight
Mancini, G., Pirruccio, K., Yang, X., Blüher, M., Rodeheffer, M. S., & Horváth, T. L. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.039 · Cited by 79
Mitochondrial Fusion Protein Mfn2 and Its Role in Heart Failure
Chen, L., Liu, B., Qin, Y. H., Li, A., Gao, M., Liu, H., & Gong, G. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.681237 · Cited by 79
Huynh, D. T. N., & Heo, K. (2021) · Archives of Pharmacal Research · doi:10.1007/s12272-021-01360-4 · Cited by 76
Mitochondrial dynamics in the regulation of neuronal cell death
Cheung, E. C., McBride, H. M., & Slack, R. S. (2007) · APOPTOSIS · doi:10.1007/s10495-007-0745-5 · Cited by 76
“The third GTPase required for mitochondrial fusion is localized to the intermembrane space and is called Opa1 [86–89].”
BackgroundInfluentialGuo, Y., Chen, K., Gao, W. D., Li, Q., Chen, L., Wang, G., & Tang, J. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.191 · Cited by 70
Self-citationTorres, G., Morales, P. E., García-Miguel, M., Norambuena-Soto, I., Cartes-Saavedra, B., Vidal-Peña, G., Moncada-Ruff, D., Sanhueza-Olivares, F., San Martín, A., & Chiong, M. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.01.013 · Cited by 67
Emerging Roles of Mitochondria ROS in Atherosclerotic Lesions: Causation or Association?
Wang, Y., & Tabas, I. A. (2014) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.23929 · Cited by 74
Mitochondrial dynamics and mitophagy in Parkinson's disease: A fly point of view
von Stockum, S., Nardin, A., Schrepfer, E., & Ziviani, E. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.11.002 · Cited by 75
Redox control of vascular smooth muscle cell function and plasticity
Durgin, B. G., & Straub, A. C. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0032-9 · Cited by 74
Anti-tumour efficacy of mitofusin-2 in urinary bladder carcinoma
Jin, B., Fu, G., Pan, H., Cheng, X., Zhou, L., Lv, J., Chen, G., & Zheng, S. (2010) · Medical Oncology · doi:10.1007/s12032-010-9662-5 · Cited by 65
“[7].”
BackgroundWu, D., Dasgupta, A., Read, A. D., Bentley, R. E. T., Motamed, M., Chen, K., Al‐Qazazi, R., Mewburn, J. D., Dunham‐Snary, K. J., Alizadeh, E., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.12.452 · Cited by 73
“The transcriptional coactivator peroxisome proliferator-activated receptor γ coactivator-1α (PGC- 1α), transcriptional regulator of Mfn2, is downregulated in human and rodent PAH PASMCs [216].”
BackgroundInfluentialSelf-citationSpurlock, B., Tullet, J. M. A., Hartman, J. L., & Mitra, K. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110919 · Cited by 61
Zhao, J., Li, J., Li, G., & Chen, M. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1059576 · Cited by 73
“They are 63% homologous, but MFN2 has an additional region of the N-terminus that can bind to RAS, suggesting functional differences between MFN1 and MFN2 (89).”
BackgroundColpman, P., Dasgupta, A., & Archer, S. L. (2023) · Cells · doi:10.3390/cells12141897 · Cited by 70
“Mitogens which are upregulated in PAH, such as PDGF and endothelin 1 (ET-1), can reduce Mfn2 expression in systemic arterial SMC [38].”
BackgroundWang, G., Zhang, Z., Xu, Z. Z., Yin, H., Bai, L., Ma, Z., DeCoster, M. A., Qian, G., & Wu, G. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.09.002 · Cited by 64
“The molecular mechanisms responsible for these alterations under the hypoxic condition have been extensively studied and indeed, a number of signaling pathways, such as the JAKs/STATs [10,11], PI3 kinase/Akt [12,13], and mitogen-activated protein kinase pathways [14,15], have been demonstrated to play important roles…”
BackgroundLasater, E. A., Bessler, W., Mead, L. E., Horn, W., Clapp, D. W., Conway, S. J., Ingram, D. A., & Li, F. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn134 · Cited by 69
“Specifically, prior animal studies indicate that increased Ras activation augments VSMC proliferation and migration, and the subsequent development of vascular lesions (26,31,32,34).”
BackgroundZhang, X., Qin, Y., Ruan, W., Wan, X., Lv, C., He, L., Lü, L., & Guo, X. (2021) · Phytotherapy Research · doi:10.1002/ptr.7149 · Cited by 70
“was capable of inhibiting the activities of Ras and affecting downstream MAPKs-related cellular apoptotic and proliferative processes (Chen et al., 2004; Guo et al., 2007).”
BackgroundSelf-citationMitofusin 2 Inhibits Angiotensin II-Induced Myocardial Hypertrophy
Yu, H., Guo, Y., Mi, L., Wang, Y., Li, L., & Gao, W. D. (2010) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248410385683 · Cited by 61
“Our previous studies have demonstrated that Mfn2 acts as an endogenous Ras inhibitor and regulates vascular proliferative processes.(8) Overexpression of Mfn2 profoundly suppresses the mitogenic stimulus-evoked proliferation of vascular smooth muscle cells via inhibiting the Ras-ERK1/2 signaling pathway.”
BackgroundMethodInfluentialSelf-citationZhou, W., Chen, K., Cao, W., Zeng, J., Liao, H., Zhao, L., & Guo, X. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.02.012 · Cited by 61
Self-citationMitofusin 2-Deficiency Suppresses Cell Proliferation through Disturbance of Autophagy
Ding, Y., Gao, H., Zhao, L., Wang, X., & Zheng, M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0121328 · Cited by 59
“In fact, in addition to meditating the membrane fusion between organelles, Mfn2 plays multiple roles in various vital cellular processes including regulation of cell proliferation and cell survival/death, maintenance of mitochondrial DNA stability, and more recently, the regulation of ER stress and autophagy[20,21,22,…”
BackgroundMitofusin-2 is a novel direct target of p53
Wang, W., Cheng, X., Lu, J., Wei, J., Fu, G., Zhu, F., Jia, C., Zhou, L., Xie, H., & Zheng, S. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.08.108 · Cited by 61
Yang, Z., Zheng, B., Zhang, Y., He, M., Zhang, X., Ma, D., Zhang, R., Wu, X., & Wen, J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.04.012 · Cited by 60
“The cell number was determined using a CountessTMAutomated Cell Counter (Invitrogen) as previously described [20] after transfection with Ad-miR-155 or Ad-GFP, or anti-miR-155, and or anti-miR-ctl in different periods.”
Self-citationGall, J. M., Wang, Z., Bonegio, R. G. B., Havasi, A., Liesa, M., Vemula, P., & Borkan, S. C. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014010126 · Cited by 57
Mitochondria orchestrate macrophage effector functions in atherosclerosis
Dumont, A., Lee, M., Barouillet, T., Murphy, A. J., & Yvan‐Charvet, L. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100922 · Cited by 60
Zhang, W., Shu, C., Li, Q., Li, M., & Li, X. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3899 · Cited by 57
Self-citationSun, D., Li, C., Liu, J., Wang, Z., Liu, Y., Luo, C., Chen, Y., & Wen, S. (2019) · DNA and Cell Biology · doi:10.1089/dna.2019.4731 · Cited by 57
“…in smooth muscle cells of hypertensive patients and platelet-derived growth factor (PDGF-BB) induced proliferating VSMC. Chen Guanghui’s research (Chen et al. , 2004) found that there was a highly conserved small p21ras-like fragment between 77 and 92 amino acids of Mfn2 protein, which possesses…”
Self-citationGet the balance right: Mitofusins roles in health and disease
Santel, A. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.02.004 · Cited by 62
“In a rat in vivo model for hypertension due to hyperplasia of vascular smooth muscle cells (VSMCs), rat Mfn2 (also referred as rHSG for rat hyperplasia suppressor gene) was identified as a potential regulator of VSMC proliferation [22,70].”
BackgroundInfluentialDasgupta, A., Wu, D., Tian, L., Xiong, P. Y., Dunham‐Snary, K. J., Chen, K., Alizadeh, E., Motamed, M., Potus, F., Hindmarch, C. C. T., et al. (2020) · Comprehensive physiology · doi:10.1002/cphy.c190027 · Cited by 67
Self-citationActivation of Mitofusin2 by Smad2-RIN1 Complex during Mitochondrial Fusion
Kumar, S., Pan, C. C., Shah, N. R., Wheeler, S. E., Hoyt, K. R., Hempel, N., Mythreye, K., & Lee, N. Y. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.04.010 · Cited by 60
“In co-immunoprecipitation studies, we first tested the degree of interaction between MFN2 and RIN1 in the presence of RAS overexpression.”
BackgroundAravamudan, B., Thompson, M., Sieck, G. C., Vassallo, R., Pabelick, C. M., & Prakash, Y. S. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25508 · Cited by 54
“Mitochondria play a major role in maintaining cellular homeostasis by regulating the balance between cell proliferation and cell death (apoptosis) (Chen et al., 2004; Guo et al., 2007; Liesa et al., 2009; Archer et al., 2010; Chalmers et al., 2012; Nagaraj et al., 2012; Rehman et al., 2012).”
InfluentialLou, Y., Li, R., Liu, J., Zhang, Y., Zhang, X., Jin, B., Liu, Y., Wang, Z., Zhong, H., Wen, S., et al. (2015) · Medical Oncology · doi:10.1007/s12032-015-0515-0 · Cited by 57
Self-citationDasgupta, A., Chen, K., Lima, P. D. A., Mewburn, J. D., Wu, D., Al‐Qazazi, R., Jones, O., Tian, L., Potus, F., Bonnet, S., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202100361r · Cited by 54
Self-citationCheng, X., Zhou, D., Wei, J., & Lin, J. (2013) · Neoplasma · doi:10.4149/neo_2013_080 · Cited by 51
Molecular Machinery and Pathophysiology of Mitochondrial Dynamics
Chiu, Y., Lin, S., Kuo, C.-H., & Li, C.-J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.743892 · Cited by 54
“Homologous mammalian genes (Mfn1 and Mfn2) regulate the fusion of the OMM and maintain the dynamic needs of reticulate mitochondria in the cell (Mishra and Chan, 2014).”
BackgroundInfluentialZhang, R., Zhou, H., Jiang, L., Mao, Y., Cui, X., Xie, B., Cui, D., Wang, H., Zhang, Q., & Xu, S. (2016) · Brain Research · doi:10.1016/j.brainres.2016.09.047 · Cited by 49
“Mitofusin2 (mfn2), a mitochondrial fusion protein, is expressed mainly in tissues with high energetic requirements, such as brain, skeletal muscle, and heart (Chen et al., 2004).”
Mitochondrial dynamics in aging and disease
Bereiter-Hahn, J. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394625-6.00004-0 · Cited by 48
Zhang, R., Han, M., Zheng, B., Li, Y., Shu, Y.-N., & Wen, J. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.96 · Cited by 48
Nottia, M. D., Verrigni, D., Torraco, A., Rizza, T., Bertini, E., & Carrozzo, R. (2021) · Genes · doi:10.3390/genes12020247 · Cited by 53
Mitochondrial Dynamics and Liver Cancer
Hernández‐Álvarez, M. I., & Antonio Zorzano, A. (2021) · Cancers · doi:10.3390/cancers13112571 · Cited by 53
“Indeed, alterations in this process have been associated with neuropathies (Charcot–Marie–Tooth type 2A and autosomal dominant hereditary optic neuropathy or ADOA) [22–24], neurodegenerative disorders such as Parkinson’s disease [25], atherosclerosis [26], and metabolic diseases such as obesity and type 2 diabetes [27…”
BackgroundFlores, E., Fernández-Novell, J. M., Peña, A., Rigau, T., & Rodríguez-Gil, J. E. (2010) · Theriogenology · doi:10.1016/j.theriogenology.2010.02.018 · Cited by 52
Yamada, S., Kubo, Y., Yamazaki, D., Sekino, Y., & Kanda, Y. (2017) · Scientific Reports · doi:10.1038/srep40925 · Cited by 50
Nie, Q., Wang, C., Song, G., Ma, H., Kong, D., Zhang, X., Gan, K., & Tang, Y. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3584-9 · Cited by 47
THE ROLE OF MITOCHONDRIA IN THE DEVELOPMENT AND PROGRESSION OF LUNG CANCER
Roberts, E., & Craig, K. J. T. (2013) · Computational and Structural Biotechnology Journal · doi:10.5936/csbj.201303019 · Cited by 52
Role of oxidative stress in the process of vascular remodeling following coronary revascularization
Gallo, G., Pierelli, G., Forte, M., Coluccia, R., Volpe, M., & Rubattu, S. D. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.05.046 · Cited by 51
Abudupataer, M., Zhu, S., Yan, S., Xu, K., Zhang, J., Luo, S., Ma, W., Alam, M. F., Tang, Y., Huang, H., et al. (2021) · eLife · doi:10.7554/elife.69310 · Cited by 50
“found that the expression of MFN2 is markedly reduced in hyperproliferative VSMCs from spontaneously hypertensive rat arteries (Chen et al., 2004).”
BackgroundSaraf, A., Oberg, E. A., & Strack, S. (2010) · Biochemistry · doi:10.1021/bi902160t · Cited by 45
“Intriguingly, while dephosphorylation of the longest GST fusion protein (Mfn2421–488) was independent of Glu153 (wild-type B′β/E153R B′β activity ratio of ~1), C-terminal truncation of this region progressively favored dephosphorylation by wild-type PP2A/B′β. Similar to TH, the shortest Mfn2 fragment encompassing Ser4…”
MethodInfluentialMitofusin 1 is required for oocyte growth and communication with follicular somatic cells
Carvalho, K. F., Machado, T. S., Garcia, B. M., Zangirolamo, A. F., Macabelli, C. H., Sugiyama, F. H. C., Grejo, M. P., Neto, J. D. A., Tostes, K., Ribeiro, F. K. S., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201901761r · Cited by 50
Amiott, E. A., Cohen, M. M., Saint-Georges, Y., Weissman, A. M., & Shaw, J. M. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-07-0622 · Cited by 45
“For example, the region just upstream of T105 (Mfn2 residues 77–91) is implicated in associations between Mfn2 and Ras that are proposed to affect ERK signaling (Chen et al., 2004; McBride et al., 2006; Pawlikowska et al., 2007; de Brito and Scorrano, 2009).”
BackgroundThe Interplay between Oncogenic Signaling Networks and Mitochondrial Dynamics
Nagdas, S., & Kashatus, D. F. (2017) · Antioxidants · doi:10.3390/antiox6020033 · Cited by 49
“In rat vascular smooth muscle cells, Mfn2 was shown to bind and sequester Ras, resulting in MAPK inhibition [64].”
BackgroundMiranda‐Silva, D., Lima, T., Rodrigues, P., Leite-Moreira, A. F., & Falcão‐Pires, I. (2021) · Heart Failure Reviews · doi:10.1007/s10741-020-10042-0 · Cited by 49
Alterations in Ca2+ Signalling via ER-Mitochondria Contact Site Remodelling in Cancer
Kerkhofs, M., Giorgi, C., Marchi, S., Seitaj, B., Parys, J. B., Pinton, P., Bultynck, G., & Bittremieux, M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-4567-7_17 · Cited by 50
Lee, Y. S., Jung, Y. Y., Park, M. H., Yeo, I. J., Im, H. S., Nam, K. T., Kim, H. D., Kang, S. K., Song, J. K., Kim, Y. R., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.07.007 · Cited by 43
Mitofusin 2 Deficiency Affects Energy Metabolism and Mitochondrial Biogenesis in MEF Cells
Kawalec, M., Boratyńska-Jasińska, A., Beresewicz, M., Dymkowska, D., Zabłocki, K., & Zabłocka, B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134162 · Cited by 46
“Growing interest of Mfn2 as a protein putatively involved in cell survival, begun when changes in Mfn2 expression in muscles of diabetic patients [3] and in blood vessels of patients suffering from vascular proliferative disorders [4] were observed.”
BackgroundThe enigma of an interconnected mitochondrial reticulum: new insights into mitochondrial fusion
Mattie, S., Krols, M., & McBride, H. M. (2019) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2019.05.004 · Cited by 44
Unravelling Ras signals in cardiovascular disease
Chien, K. R., & Hoshijima, M. (2004) · Nature Cell Biology · doi:10.1038/ncb0904-807 · Cited by 41
Archer, S. L. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-7678-9_3 · Cited by 44
Zhuang, X., Maimaitijiang, A., Li, Y., Shi, H., & Jiang, X. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4541 · Cited by 42
“An increasing number of studies (14,15) have identified a variety of proteins involved in mitochondrial dynamics that are associated with VSMC proliferation, which therefore implicates these proteins as potential drug targets.”
BackgroundProteins That Fuse and Fragment Mitochondria in Apoptosis: Con-Fissing a Deadly Con-Fusion?
Scorrano, L. (2005) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-005-6572-x · Cited by 50
Mitofusin 2 (Mfn2): a key player in insulin-dependent myogenesis in vitro
Pawlikowska, P., Gajkowska, B., & Orzechowski, A. (2006) · Cell and Tissue Research · doi:10.1007/s00441-006-0320-3 · Cited by 42
“Each experiment was repeated at least twice with similar results reported by Chen et al. (2004) who showed that Mfn2 negatively controlled vascular smooth muscle cell proliferation.”
BackgroundResultMitochondria-Directed Therapeutics
Armstrong, J. S. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1929 · Cited by 43
“…involved in organelle membrane dynamics, increasing evidence suggests that MFN2 is involved in multiple signaling pathways in addition to its role in the regulation of mitochondrial fusion, including the regulation of mitochondrial metabolism (40), cell cycle progression (12), and apoptosis (31).”
Arterial remodeling: the role of mitochondrial metabolism in vascular smooth muscle cells
Qin, H.-L., Bao, J., Tang, J., Xu, D., & Shen, L. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00074.2022 · Cited by 41
Self-citationMitochondrial Dysfunction: Metabolic Drivers of Pulmonary Hypertension
Suliman, H. B., & Nozik‐Grayck, E. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7705 · Cited by 39
“Due to its antiproliferative effect, MFN2 was initially referred to as hyperplasia suppressor gene (22).”
BackgroundMa, L., Liu, Y., Geng, C., Qi, X., & Jiang, J. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1903 · Cited by 39
“Chen et al (10) recently demonstrated that mfn2 profoundly suppresses cell growth and proliferation in multiple tumor cell lines and rat vascular”
InfluentialMetabolism, Mitochondrial Dysfunction, and Redox Homeostasis in Pulmonary Hypertension
Hidalgo, D. C., Elajaili, H. B., Suliman, H. B., George, M. P., Delaney, C. A., & Nozik‐Grayck, E. (2022) · Antioxidants · doi:10.3390/antiox11020428 · Cited by 44
“For example, when cloned, MFN2 was found to have an antiproliferative effect [68,69].”
BackgroundPang, W., Zhang, Y., Zhao, N., Darwiche, S. S., Fu, X., & Xiang, W. (2013) · Placenta · doi:10.1016/j.placenta.2013.03.013 · Cited by 42
Adenovirus-expressed human hyperplasia suppressor gene induces apoptosis in cancer cells
Wu, L., Li, Z., Zhang, Y., Zhang, P., Zhu, X., Huang, J., Ma, T., Lu, T., Song, Q., Li, Q., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0382 · Cited by 40
“as a cell proliferation suppressor (1).”
BackgroundSelf-citationAcquired disorders of mitochondrial metabolism and dynamics in pulmonary arterial hypertension
Breault, N. M., Wu, D., Dasgupta, A., Chen, K., & Archer, S. L. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1105565 · Cited by 39
“When first discovered, MFN2 was also referred to as hyperplasia suppressor gene because of its antiproliferative effect in SMC (Chen et al., 2004).”
BackgroundSelf-citationTracy, E. P., Hughes, W. E., Beare, J. E., Rowe, G., Beyer, A., & LeBlanc, A. J. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0031 · Cited by 44
Xia, F., Chen, X., Zhong, G., Chen, Q., & Hu, C. (2015) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000333 · Cited by 38
“Moreover, Mfn2 was able to promote vascular smooth muscle cell (VSMC) apoptosis by inhibiting the Ras-Raf-MAPK and Ras-PI3K-Akt pathways.(13,14) Apoptosis, also called programmed cell death, is important for maintaining intracellular and tissue homeostases.”
BackgroundXin, Y., Wu, W., Qu, J., Wang, X., Song, L., Yuan, L., & Liu, X. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3649808 · Cited by 36
Peroxisome proliferator-activated receptor δ regulates mitofusin 2 expression in the heart
Li, Y., Yin, R., Liu, J., Wang, P., Wu, S., Luo, J., Zhelyabovska, O., & Yang, Q. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.02.020 · Cited by 37
“Mfn2 is highly expressed in heart, skeletal muscle and brain [6,8,9].”
BackgroundEarly protective effect of mitofusion 2 overexpression in STZ-induced diabetic rat kidney
Tang, W. X., Wu, W. H., Zeng, X., Bo, H., & Huang, S. (2011) · Endocrine · doi:10.1007/s12020-011-9555-1 · Cited by 37
Astrogliosis and glial scar in ischemic stroke - focused on mechanism and treatment
Chen, W., Su, G., Chai, M., An, Y., Song, J., & Zhang, Z. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.115131 · Cited by 40
MA, L., CHANG, Y., Yu, L., He, W., & Liu, Y. (2015) · Oncology Letters · doi:10.3892/ol.2015.3748 · Cited by 35
“…membrane, a possible protein kinase A or G phosphorylation site and a p21 (Ras) signature motif (amino acids 77-92), which plays an essential role in signaling (4,18) In our previous study, we suggested that E2 induces the proliferation of MCF-7 cells by downregulating the expression of Mfn2 (12).”
InfluentialLv, J., Wen, W. X., Jiang, C. C., Fu, Q., Gu, Y., Lv, T., Li, Q., & Xue, W. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.98 · Cited by 34
Self-citationRetractedCormio, A., Sanguedolce, F., Musicco, C., Pesce, V., Calò, G., Bufo, P., Carrieri, G., & Cormio, L. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.07.001 · Cited by 37
Energy and Redox Homeostasis in Tumor Cells
de Oliveira, M. F., Amoêdo, N. D., & Rumjanek, F. D. (2012) · International Journal of Cell Biology · doi:10.1155/2012/593838 · Cited by 38
Silver nanoparticles inhibit neural induction in human induced pluripotent stem cells
Yamada, S., Yamazaki, D., & Kanda, Y. (2018) · Nanotoxicology · doi:10.1080/17435390.2018.1481238 · Cited by 33
“A previous report indicates that Mfn1 directly binds to Ras and Raf, resulting in the inhibition of the Ras–Raf–ERK signaling pathway by the biochemical analysis (Chen et al. 2004, 2014).”
BackgroundThe promoter activity of human Mfn2 depends on Sp1 in vascular smooth muscle cells
Sorianello, E. M., Soriano, F. X., Fernández‐Pascual, S., Sancho, A., Naón, D., Vila-Caballer, M., Navarro, H. G., Portugal, J., Andrés, V., Palacín, M., et al. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs006 · Cited by 34
“The transient repression of Mfn2 detected early after the implementation of an atherogenic diet is similar to the transient repression of Mfn2 detected in carotid arteries after a mechanical injury induced by angioplasty.(6) In keeping with the observations in the aorta, VSMCs showed a parallel reduction in Sp1 and Mf…”
BackgroundResultZhang, L., Yuan, X., Wang, S., Ou, Y., Zheng, X., & Wang, Q. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.05.025 · Cited by 31
Metadata
- Authors
- Chen, K.-H., Guo, X., Ma, D., Guo, Y., Li, Q., Yang, D., Li, P., Qiu, X., Wen, S., Xiao, R.-P., & Tang, J.
- Affiliations
- National Institutes of Health (US)
- Peking University (CN)
- Corresponding author
- Xiao, Rui-Ping
- ORCID
- Venue
- Nature Cell Biology
- Published
- 2004-08-22
- Volume
- 6
- Issue
- 9
- Pages
- 872-883
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W2104828119
- Cited by
- 370
- References
- 50
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 6 · 2023: 12 · 2022: 26 · 2021: 22 · 2020: 18 · 2019: 19 · 2018: 22 · 2017: 18 · 2016: 21 · 2015: 24 · 2014: 20 · 2013: 32 · 2012: 26
- FWCI
- 4.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Surgery › Cardiovascular, Neuropeptides, and Oxidative Stress Research
- Keywords
- HSG, mitofusin 2, vascular smooth muscle cell proliferation, restenosis, intimal hyperplasia, atherosclerosis, ERK/MAPK signalling, cell cycle arrest, mitochondrial targeting, mitochondrial fusion, spontaneously hypertensive rats, balloon injury, ApoE-deficient mice
- MeSH terms
- Animals, Arteriosclerosis, Cardiovascular Diseases, Cell Division, Gene Expression Regulation, Humans, Membrane Proteins, Molecular Sequence Data, Muscle, Smooth, Vascular, Oncogene Protein p21(ras), Mice, Knockout, GTP Phosphohydrolases, MAP Kinase Signaling System, Coronary Restenosis, Mitochondrial Proteins, Myocytes, Smooth Muscle, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.